With an integrated background in sciences and business, Jingjing is excited to help advance innovative life-changing therapeutics for patients in need. Jason led the firms investments and served as a Director of Ra Pharmaceuticals (acquired by UCB) and Vapotherm (NASDAQ: VAPO). NEW YORK The Lightstone Group, LLC, one of the largest private real estate owners in the country, announced today that an affiliate has entered into an agreement with affiliates of The Blackstone Group to acquire Extended Stay Hotels for $8 billion. Type of business: Privately held company. During his time at Split Rock, Jason was actively involved with the firms investment in Ardian (acquired by Medtronic), Cabochon Aesthetics (acquired by Ulthera), Atritech (acquired by Boston Scientific), Entellus Medical (acquired by Stryker), Evalve (acquired by Abbott), and Transcend Medical (acquired by Alcon). The company has utilized its proprietary discovery platform to develop a portfolio of competitively differentiated therapeutic programs. Jason brings 20 years of operating and venture experience in the life sciences and also is a General Partner at Morgenthaler Ventures. in Management Science from the University of California, San Diego, Ph.D. Read More. Postdoc Neuroscience Drug Discovery, University Health Network, University of Toronto, Bachelor of Accounting from Nanyang Technological University, Singapore. Lichtenstein stated in an interview that outlet malls at the time had become an "out-of-favor stock in an out-of-favor industry". [12] While expanding the diversity of investments, he also moved into hospitality in 2007 with his biggest single deal to date. Atsena Therapeutics is a clinical-stage gene therapy company focused on developing novel therapeutics to prevent or reverse blindness. [29], Bill de Blasio appointed Lichtenstein to the NYC Economic Development Corporations Board of Directors in 2015. million verified professionals across 35 million companies. In 2007, The Lightstone Group acquired Extended Stay Hotels for $8.1 billion and sold Prime Retail in 2010 for $2.1 billion, earning a large profit from the sale of the outlet mall group. Lightstone Group has plotted a move south to tap into investment opportunities in burgeoning Southeast markets, Commercial Observer has learned. Mark joined MIS as one of the initial members of the companys engineering team and remained there through the acquisition by Medtronic. She is an observer to the board of Carrick Therapeutics, Cerevance, and FIRE-1. In 1992-1993, Hanson co-founded and served as Managing Director of Bavaria Medizin Technologie, GmbH in Oberpfaffenhofen, Germany. At Lightstone, we believe investing in large-scale, commercial real estate shouldnt be limited to large corporations, institutions, or high net worth individuals. Our team works hands-on with founders to help establish a strategy that can transform their vision into commercially viable products. EB-5 Raised. Morgenthaler Ventures has exited the investment since IPO. [4] The acquisition made Lichtenstein the owner of a number of famous buildings and properties in Chicago, where Prime Retail had previously been based. His strategy differed from that of many major investors at the time, as he stated, "do you want to go to a fishing hole where there's a lot of other people fishing, or do you want to be where you're the only guy with a hook in the water? During the early years of the Lightstone Group, Lichtenstein focused on investing in multifamily properties. engagement. The company was acquired by QLT Inc. (NASDAQ: QLTI) in 2007. Operating in all sectors of the . Hanson is also a Managing Partner at The Foundry, LLC, a medical device company incubator and a preferred partner to LSV. Earlier in his career, Mike served as a Director of Business Development for Inhale Therapeutic Systems (now Nektar Therapeutics, NASDAQ: NKTR), a venture-backed pulmonary drug delivery company that went public in 1994. Jean is a General Partner of Lightstone Ventures. A real estate investment trust is a company that owns, and in many cases, manages income-producing real estate. Lightstone provides information, valuations and market intelligence on properties in South Africa. As Chairman and CEO, David Lichtenstein has lead the Lightstone Group to become one of the largest privately held real estate companies in the United States. At ForSight Labs, an Ophthalmology-focused incubator started by Hanson, Eugene de Juan, MD, and K. Angela Macfarlane, successes include Transcend Medical (acquired by Alcon), Forsight Newco 2 (acquired by QLT), Forsight Vision 4 (acquired by Genentech/Roche), and Forsight Vision 5 (acquired by Allergan). David Lichtenstein Net Worth Professional Journey You will see him often in social media. She began her career at PricewaterhouseCoopers Singapore where she focused on the financial services industry, specializing in the provision of regulatory advisory and audit services to banks and asset managers. Orexigen Therapeutics is a biopharmaceutical company developing therapies for the treatment of obesity. Real estate portfolio. Promedior is a clinical stage biotechnology company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Shoulder Innovations, Inc. is a medical device company developing and commercializing an innovative shoulder replacement system which addresses the greatest cause of surgical failure: glenoid loosening. The Foundry is the premier medical device company incubator and a preferred partner to LSV. Lightstone team members have been involved in some of the largest venture-backed life science exits over the last decade including: Ardian, Acceleron, ALX Oncology, Calithera BioSciences, Claret Medical, Disarm Therapeutics, MicroVention, Nimbus, Plexxikon, Portola Pharmaceuticals, Promedior, Proteolix, Ra Pharma, Tizona Therapeutics, Twelve and Zeltiq. Mini Biography. Investors purchase shares within the REIT and receive a pro-rata share of income that is derived from the real estate. He implemented the vision of a company unit following biology across therapeutic areas while generating advanced antibody technologies and turned Rinat into the center of cancer immunology for Pfizer. Lightstone owns more than 10,000 individual apartment units and some 20 million sq. Looking for a particular Lightstone Group employee's phone or email? Nuvaira is a medical device company developing novel devices for treating obstructive lung diseases. During her time in pharma she held a number of operational roles, predominantly focused on oncology, such as product management, strategic marketing, business development and regulatory affairs. Its lead program was acquired by Gilead Sciences (NASDAQ: GILD) in 2016. Yvonne holds a Ph.D. in Biochemistry from the University of Wisconsin, Madison and a B.Sc. [37] "We are fortunate to have the ability to house families affected by this traumatic event and can only hope that in some small way, those affected by this tragedy will be able to take some comfort in receiving this temporary shelter", Lichtenstein said. Purchasing Administrator. [35], Lichtenstein is a trustee of the Supervisory Committee for The New York Medical College, and is also a trustee of The Touro College and University System and sits on the Board. COMPANY DESCRIPTIONLightstone, founded by David Lichtenstein, is one of the most diversified privately held real estate companies in the United States. The value-add portfolio spans 7,810 apartments, consisting primarily of one- and two-bedroom units, according to documents filed with the Tel Aviv Stock Exchange (TASE). The company successfully completed an IPO in 2012. Cons. Cannot keep help on sites due to underpayment and micromanagement by regional staff. Caroline spent 9 years at Bayer Healthcare, most recently serving on the board of senior management of Bayer Ltd. Ireland as head of market access, pricing and reimbursement. Jingjing has a background in neurobiology and life sciences strategy. (212) 616-9969. The company was acquired by Pfizer (NYSE: PFE) in 2010. The company was acquired by Eli Lilly (NYSE: LLY) in 2007. in Finance from University of Missouri, B.S. Most Read News : 2022: Analysis-Wood's ARK slammed by higher interest rates in 2022 along with other growth funds: RE. REITs. Jason Lettmann is a General Partner of Lightstone Ventures and focuses on investments in the biopharmaceutical and medical technology sectors. Acceleron Pharma is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics to treat serious and rare diseases. [3] Over a three-year period, Lichtenstein reinvested capital from his properties to fund the down-payments on more properties. We not only back our companies financially, but we partner with them to navigate their day-to-day functions. Brendan is a Vice President at Lightstone Ventures evaluating opportunities in the biopharmaceutical sector. Dr. Treco was a Visiting Scientist in the Department of Molecular Biology at Massachusetts General Hospital and a Lecturer in Genetics at Harvard Medical School from 2004 to 2007. $6.5 Billion. Lightstone Group Gets $300M Construction Loan For 800-Foot Condo Tower Mar 13, 2017 Kouichi Shirayanagi, Bisnow New York Multifamily + National DICE Construction, Design & Development Series -. He rapidly grew his portfolio in the 1990s, before diversifying his portfolio and moving into retail. Lightstone Group is a Real Estate, Commercial, and Retail company located in New York, New York with $283.00 Million in revenue and 224 employees. Mitchell Hochberg, president, of the Lightstone Group. He then leveraged the new properties with loans, allowing Lichtenstein to continue to add to his portfolio. [26][27], Following Amazon's decision to abandon its plans to build a headquarters in Queens, Lichtenstein called it the "worst day for NYC since 9-11," adding that "this time, the terrorists were elected. Bard. Sage Hospitality and The Lightstone Group are pleased to announce the signing of a franchise license agreement with Hilton Worldwide for a new DoubleTree by Hilton hotel location in Danvers, Mass. Lightstone's primary competitors include Hunt, CDT, Marcus & Millichap and 20 more. He assists the LSV medical device team with deal sourcing, due diligence, and portfolio company management. The company was acquired by Alcon (Novartis) (NYSE: NVS) in 2016. [15] Lightstone Value Plus was the 18th-largest non-traded United States-based REIT, with a dividend of 7 percent. Second Genome is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics identified using microbiome science. David Lichtenstein is the Chief Executive Officer & Chairman at Lightstone based in New York City, New York. Weve built our reputation on our ability to identify opportunities early, analyze their potential, and transform them into above-market investments. The company successfully completed an IPO in 2022 (NASDAQ: VIGL). The company was founded by David Lichtenstein in 1988. Marilyn Lightstone Net Worth is $1.5 Million. What defines us: Our experience spans all stages of company growth Our team collectively has nearly 100 years of company-building experience. Before joining Lightstone, Jingjing was a Life Sciences Consultant at L.E.K. Avidia is a biopharmaceutical company discovering and developing a new class of human therapeutic proteins called Avimer. The company was incubated within The Foundry, the premier medical technology incubator, and was acquired by Medtronic (NYSE: MDT) in 2015. The boom was good for the existing portfolio Lichtenstein had amassed, but it made it more difficult to find affordable properties to purchase. Jingjing attained her Ph.D. in neurobiology at Duke University. In September 2012, Lightstone Group announced they would be purchasing a $51 million residential development in Long Island City. (business & personal). View Highlights of The Lightstone Story Below. Lightstone has finalized a deal to buy a portfolio of 27 multifamily assets in suburban Detroit for $1 billion from Hartman & Tyner, the company announced. Stacy is an Operating Partner of LSV and assists the LSV medical device team with deal sourcing, due diligence, and portfolio company management. Young is also a member of the board of directors of ADMA Biologics, (Nasdaq: ADMA), a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics. ForSight VISION5 is a medical device company focused on a novel anterior segment drug delivery program for ophthalmic drugs. Prior to Lightstone, she was Deputy Director at the National Research Foundation, a division of the Prime Ministers Office Singapore, where she led the formulation of innovation policy, implemented innovation grants and managed various technology translation platforms in the life sciences sector. Our Property Toolkit gives subscribers access to a set of tailored Residential Property reports. Lichtenstein has donated significantly to many Jewish institutions both in and out of New York. [16] Following the success of Lightstone Value Plus, Lichtenstein launched a second non-traded REIT. As an organization, Lightstone is all about the spirit of excellence & professionalism and has the passion & confidence to achieve goals. Principia was acquired by Sanofi (NASDAQ: SNY) in 2020. The company was acquired by Boston Scientific (NYSE: BSX) in 2018. The company was incubated within The Foundry, the premier medical technology incubator, and was acquired by Ulthera in 2014. He even shared some of his business tactics by saying that it is clever to buy land, instead of the homes that are built on it. The company was acquired by Eisai Inc. (TYO: 4523) in 2007. No work/life balance. "Why one investor bought land instead of homes during the housing bust", September 30, 2014, "Lichtenstein: Social Trends Could Redefine Real Estate", "Mayor de Blasio Appoints New Members to NYCEDC Board of Directors", "The List of CRE Companies Donating Office Space Through City Program Continues to Grow", "Lightstone donates office space to businesses displaced by Sandy", "Lightstone donates office space at 1407 Broadway - Real Estate Weekly", "Headlines: A Common Sense Haredi Approach", The Lightstone old page design, About David Lichtenstein Page, https://en.wikipedia.org/w/index.php?title=David_Lichtenstein&oldid=1116690320, This page was last edited on 17 October 2022, at 21:10. Lastly, Mike served as a Director on the National Venture Capital Association (NVCA) Board of Directors and remains active in helping to shape policy affecting both innovation and healthcare. In late 2010, REITs raised an estimated $9 billion, with a 6.5 percent annual yield. He is a co-inventor on over 250 issued and pending U.S. patents. Before Pfizer, Dr. Pons created and led Rinats protein engineering group and was a scientist at Chiron. So, how much is Marilyn Lightstone worth at the age of 82 years old? Brendan was previously a life sciences strategy consultant at L.E.K. At the time, it was said the hotel group had 683 hotels across 44 US states and Canada. Vigil is utilizing modern neuroscience drug development across multiple therapeutic modalities to deliver precision-based therapies to improve the lives of patients and their families. Lightstone Ventures was founded in 2012 to empower big-thinking founders with vision and commitment to bring innovative therapeutics to patients in need. A Company You Can Trust. Prior to being part of the founding teams of Magenta and Decibel, Christina held operational roles at Ironwood Pharmaceuticals (NASDAQ:IRWD) in corporate development. Principia Biopharma is a biopharmaceutical company developing novel compounds with enhanced sensitivity, high potency and longer duration of effect. Press from David Lichtenstein and the Lightstone Group Press releases about David Lichtenstein and the Lightstone Group The Lightstone Group was founded in 1988 by David Lichtenstein. Hong I. Wan, Ph.D. is president, chief executive officer and co-founder of Tallac Therapeutics. [6], In the 1990s, Lichtenstein grew The Lightstone Group's portfolio to over 20,000 apartments in 28 states. She currently serves as a director on the board of Ligature Therapeutics Pte. ForSight VISION2 is a medical device company that developed a proprietary ocular punctal plug drug delivery system. At Inhale, Mike led partnering activities with a number of pharmaceutical and biotechnology companies in the U.S., Europe, and Japan. He rapidly grew his portfolio in the 1990s, before diversifying his portfolio and moving into retail. View Highlights of The Lightstone Story Below. [7], After seeing the potential of the single mall in Puerto Rico, Lichtenstein made his first major deal in the real estate market in 2003. Includes a $ 40-million River Parcel for. He has served in this role since November 2013. Before joining Lightstone in 2021, Christina was part of the founding team and Chief Business Officer at Magenta Therapeutics where she was accountable for portfolio strategy and management, program management, business development, alliance management and commercial strategy. The Lightstone Group has raised a total of $644M in funding over 5 rounds. in Mechanical Engineering from Cornell University, Ph.D. Neuroscience from Tufts University School of Medicine, Graduate School of Biomedical Sciences, B.S. Contact for The Lightstone Group: Ed Tagliaferri: 212 981 5182 / edmund_tagliaferri@dkcnews.com Michael Paluszek 212 981 5149 / michael_paluszek@dkcnews.com. Show more Lightstone Group & Affiliates website Learn more Jobs He has served in this role since November 2013. Ligature is an early stage biopharmaceutical company focused on the research and development of small molecule drugs designed to degrade undruggable disease-causing proteins with precision, delivering new therapies for intractable cancers. The company was acquired by Roche Holding (OTCMKTS: RHHBY) in 2019. More than 17 million square feet of office space in lower Manhattan had been shuttered in Sandy's aftermath. Previously Ken was a consultant to the life science industry. Lightstone Group Leasing Consultant He previously served on the boards of nine companies that were acquired Claret Medical, Miramar Labs, Twelve Medical, Ardian, Access Closure, Acclarent, Cabochon, EPI and TransVascular. We lead the market through creative planning, visionary design, and operational excellence. To learn about leasing opportunities throughout The Lightstone Group's portfolio of office and retail properties, contact Jeff Dash at (908) 668-8300 or jdash@lightstonegroup.com. Plain serves on the boards of Earlens, Nuvaira, Moximed and Setpoint. Prior to starting Calithera, Dr. Molineaux was a co-founder of Proteolix and served as the CSO for two years before becoming President and CEO of the company. The complex features two- to five-bedroom apartments, a maisonette, and a duplex penthouse with a private rooftop terrace. ft. of commercial space, primarily in the Northeast, Southeast, and South. Travis is responsible for all aspects of accounting, tax, reporting, and compliance for LSV and ATV. Using a thesis-driven investment strategy, we focus on understanding key market sectors and seeking out disruptive technologies while building and nurturing relationships with key thought leaders. Subsequently, recapitalized with Simon Property Group for $2.3b in December 2009, one of the firms most noteworthy successes, A public non-listed REIT, current AUM $509mm, 199-unit luxury rental property in Long Island City, Queens, 430-unit luxury rental property in Gowanus, Brooklyn, Awarded Development Project of the Year at ALIS (the American Lodging Investment Summit), Winner of Conde Nast Travelers 2020 Readers Choice Award Top 25 Hotels in NYC, 428-unit luxury rental property in Long Island City, Queens, Received Boutique Designs 2019 Goldkey Award for Best Midscale Hotel and Surface Magazines 2019 Travel Award for Best Micro-Hotel, Recognized as one of Business Insiders Top 20 NYC Hotels, Winner of Hospitality Designs Award for Best Select Service Hotel, 28-unit luxury condominium property in New York, NY, Bonds are rated A+ by Standard & Poors Maalot, 242-unit luxury condominium property in New York, NY, 202-room lifestyle hotel in South Beach, Miami, The acquisition from Hartman & Tyner increased Lightstones multifamily portfolio to over 23,000 units, Industrial and Retail Commercial Management, Investing and Developing Across The Country. NEW YORK, NY--(Marketwire - Jul 12, 2012) - The Lightstone Group, a national real estate developer, announced today the expansion of its Securities. Caroline has over 10 years operational experience in the pharmaceutical industry. The Lightstone Group is a privately held real estate investment firm founded in 1988 by David Lichtenstein. The company is developing a novel treatment solution for patients with symptomatic BPH designed to be safely and effectively performed in a doctors office setting in a simple procedure under local anaesthesia. She has been recognized as one of the Top 100 Women in Business and is a frequent speaker on healthcare, innovation leadership and corporate culture. Lightstone has invested directly in individual real estate assets and in real estate operating companies. Prior to The Foundry, Hanson was Vice President of Research and Development at Heartport, Inc., which had a successful IPO in 1996. $1 Million - $5 Million. Lightstone Group Leasing Consultant Troy, MI Easy Apply 4d $33K-$42K Per Year (Glassdoor est.) Ra Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of drugs with the specificity of antibodies and the oral bioavailability of small molecules. Lightstone Group was founded by David Lichtenstein in 1988 and is based in New York. Vapotherm is a medical device company pioneering Hi-VNI technology, a less invasive form of support for patients in respiratory distress. [32], Lightstone continues to seek new acquisitions across the United States in both urban and suburban locations and across a wide range of property types, including industrial, office, retail, multifamily and hospitality. Make all checks payable to "Lightstone Value Plus REIT II Inc." Payments may be wired to: (send the original subscription agreement to the address above) Expected to do 60 hrs of work per week with only 40 hrs of pay. B.S. Jason was also previously a co-founder and on the Board of Tarsus Medical before its acquisition by Integra Life Sciences in 2013. [53][54], Lichtenstein is the author of three books on the Orthodox Jewish perspective on current events and contemporary topics including terrorism, gay marriage, abortion, missionary activities, insanity, genetics, and vaccinations and has also authored a commentary on the Mishna Berura that presents the positions of many contemporary halachic authorities in relation to the text. Featured on the Forbes Midas List of top technology and life science investors, Mike is a recognized thought leader in the industry and a frequent speaker at healthcare conferences. He is currently the Chief Financial and Operating Officer at Alchemab Therapeutics, an LSV portfolio company focused on developing novel antibody therapeutics generated from patients resilient to disease. We have been part of start-up ventures of all stages and played a critical role in evaluating, guiding, and building successful healthcare companies. Mr. Jason also served as the interim CEO of Promedior and led the company through its sale to Roche in 2020. [25] The loans from Israel were used to underwrite a number of developments in Brooklyn's Gowanus Canal area. Over the course of her career, Stacy has been involved in the launch of over 20 medtech technologies, more than 10 substantive M&A transactions, and under her operating leadership, a reputation of achieving world class customer and employee The company successfully completed an IPO in 2015. Young was most recently Chief Financial and Business Officer at Momenta, where he had responsibility for business development, strategy, finance, investor relations, and commercial. No credit card required. Operating in all sectors of the real estate market, Lightstone's $2 billion portfolio currently includes over 6 million square feet of office, retail and industrial commercial properties, 11,000 residential units and 3,200 hotel keys. Developing the next generation of percutaneous left ventricular assist devices. They included the IBM Plaza, 208 South LaSalle Street and the United Building. ZELTIQ is a medical device company developing and marketing a non-invasive, office-based procedure that uses Cryolipolysis, a proprietary cooling technology, to eliminate fat. In 2020, Gilead Sciences (NASDAQ: GILD) purchased an option to acquire ~50% of the company. Goldman Sachs Bank USA and CapitalSource are the most recent investors. It also owns over 12,000 land lots across the country. [4] The REIT, named Lightstone Value Plus, had a fund value of $300 million and aimed to invest in a mix of office, retail and other commercial properties. Medicinal Chemistry, Trinity College Dublin Ardian is a medical device company developing catheter-based therapies to treat hypertension and related conditions. Mr. The company was incubated within ForSight Labs and was acquired by Allergan (NYSE: AGN) in 2016. [22][23], In 2013, Lichtenstein and Marriott completed their first deal, the purchase of three Marriott-branded hotels in Iowa and Ohio for $21 million. Stacy also serves as Chairwoman of the Board for both CALA Health and Contego, an Independent Director for Vesper Medical, as well as a Director for the Fogarty Institute, a non-profit educational innovator. [33][34] Lichtenstein is a trustee of the Citizens Budget Commission, and is a Member of the Real Estate Roundtable and Co-Chair of the Real Estate Capital Policy Advisory Committee. Brendan has a background in medicinal chemistry and computational drug discovery research, and life sciences strategy. Lost multiple good employees due to regional management being rude or hateful towards the staff. [14], Lichtenstein's Lightstone Value Plus was one of a number of REITs attracting attention from investors, due to market instability. The company invests in income-producing multifamily and commercial, mostly retail, real estate in the US. MediSix Therapeutics is an early-stage cell therapy company that is taking a novel approach to develop chimeric antigen receptor (CAR) T cells to target T cell lymphoma and leukemia. [17], The sale of Prime Retail and both REITs gave Lichtenstein a large fund to invest throughout 2011. He currently serves on the Board of Directors of ALX Oncology (NASDAQ: ALXO), Atsena Therapeutics, Carrick Therapeutics, Cerevance, FIRE1, Relievant Medsystems, and Second Genome. Education : Sainik School Admission RBSE 12th, 10th Exam 2023 CTET 2023 RRB Group D PET Admit Card 2022: AUTO : Tata All Cars Price of January 2023 Sonalika Tractor Lexus India Skoda Sales Report 2022. By Mack Burke July 14, 2021 7:00 am. Lichtenstein has more recently been involved in New York City real estate and is playing a large role in the redevelopment of Brooklyn and the Gowanus Canal area of the borough. No breaks. Mark joined The Foundry at its inception in 1998. Lightstone Group Completes $2.3 Billion Disposition of Prime Outlets Client News According to reports, there was an estimated $350 million remaining from the Prime Retail sale, which was reinvested into new deals. Prior to that he was a partner in the pharmaceutical practice at Booz-Allen & Hamiliton. As an organization, we nurture an entrepreneurial mindset and encourage our employees to do the same; always striving to raise the bar, think outside the box, and be world-class in all we do. Recently she held multiple CEO roles at medical device startups such as Cala Medical (developing a novel blood purification cartridge for sepsis) and Capri Medical (developing an implantable neurostimulation device for migraines). Lichtenstein was born in 1960 into a Jewish family in New York City, United States. For questions or more information, please contact. The company successfully completed an IPO in 2018. Disarm Therapeutics is a biotechnology company that is creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease-causing disability and disease progression. [42] Lichtenstein also has a weekly radio show which covers the Jewish perspective on a different controversial topic each week. Vigils purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brains immune system. [9], By the end of 2003, Lightstone was recognized as one of the largest and most active property buyers in the United States. EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based and incisionless surgical technology for the treatment of GERD. The company successfully completed an IPO in 2013. Mr. Lichtenstein personifies Lightstone's commitment to the highest standards of quality, integrity, and value. in Biology from St. Josephs University, Ph.D. in Molecular and Cell Biology from the Institute on Fundamental Biology, Barcelona, Ph.D. in Molecular and Cell Biology from University of California, Berkeley, Ph.D. in Molecular Biology from University of a Southern California Tallac Therapeutics is a biopharmaceutical company focused on the research and development of CpG-Antibody conjugates intended to stimulate the immune system in the treatment of cancer. Invest with One of the Largest Privately Held Real Estate Companies in the U.S. 100% USCIS Approval Trusted Worldwide by Over 1,000 Families Talk to An Expert Today $6.5 Billion Real Estate Portfolio A+ and A1 Credit Ratings from S&P and Moody's Over $530 Million EB-5 Raised 30+ Years Investment Track Record Contact. Contego Medical is a Raleigh-based medical device company developing a suite of products for the treatment of neurovascular, coronary and peripheral vascular disease. Previously, Mark held engineering positions with Devices for Vascular Engineering, Cordis Corporation and the USCI Division of C.R. Previously as chief scientific officer and a member of the founding management at ALX Oncology, she led the team to advance ALX148, a best-in-class myeloid checkpoint inhibitor, for multiple tumor indications. From 1989 until 1994 she was a scientist in the immunology group at Merck, in Rahway, NJ. No work/life balance. Their latest funding was raised on Dec 19, 2019 from a Debt Financing round. Lightstone has a total AUM of $1.5 billion across five non-traded REIT offerings, including: Lightstone Value Plus REIT, Inc., Lightstone Value Plus REIT II, Inc., Lightstone Value Plus REIT III, Inc., Lightstone Real Estate Income Trust, Inc., and Lightstone Value Plus REIT V. For questions or more information, please contact investorservices@lightstonegroup.com. Starting with an $89,000 investment in a two-family house in 1986, founder David Lichtenstein has grown Lightstone into one of the most innovative and diversified privately held real estate firms in the United States. Previously, Mark was a senior member of the Research & Development team at Medtronic Micro Interventional Systems. Hanson is a Partner of LSV. The Lightstone Group net worth 3.12 Million Millions of dollars 86% Net worth score Disclamer: The Lightstone Group net worth displayed here are calculated based on a combination social factors. info@lightstonegroup.com. The company successfully completed an IPO in 2007. 4. Last Update. The company was acquired by Onyx Pharmaceuticals (NASDAQ: ONXX) in 2009. PowerVision is a medical device company developing a proprietary fluid-controlled accommodating intraocular lens (IOL) technology to restore the vision of youth to millions of middle-aged or elderly individuals. REITs offer distinct advantages for investors, including portfolio diversification and income through a transparent and regulated operating structure. free lookups / month. Originally trained as a Ph.D. in Neuroscience, leading the integration of science and medicine with business is a fundamental objective in her career. The show is well known for including interviews with various prominent Rabbis and Jewish community leaders and the lineup of personalities interviewed includes both Haredi and Modern Orthodox leaders. Portola Pharmaceuticals is a biopharmaceutical company developing innovative therapeutics for cardiovascular and autoimmune/inflammatory diseases. Success stories include Evalve (acquired by Abbott), Concentric (acquired by Stryker), Ardian (acquired by Medtronic), Twelve (acquired by Medtronic). Christina Isacson is a Partner of Lightstone Ventures and focuses on investments in the biopharmaceutical sector. Caroline joined Lightstone Ventures in 2017 and evaluates new investment opportunities in the biopharmaceutical and medical device sectors out of the firms Dublin office. Hypnion is a biopharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders such as sleep, wake-alertness disorders and circadian rhythm abnormalities. in Public Policy from Michigan State University, B.S. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms, financial advisors and other financial institutions and investors on their most important mergers, acquisitions and takeover transactions. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. This site is accessible to approved users only. Yvonne was also the Vice-President of Biotech Connection Singapore, where she worked closely with innovators, community leaders, academics and investors in shaping a vibrant life sciences startup ecosystem in Singapore. He assists the LSV biopharmaceutical team with deal sourcing, due diligence, and portfolio company management. [6], Lichtenstein announced in 2006 that he would be launching a real estate investing trust (REIT), which allowed Lightstone to raise capital from outside investors. Lightstone Group & Affiliates Careers and Employment About the company Founded 2004 Company size 201 to 500 Revenue $500M to $1B (USD) Industry Real Estate Headquarters 460 Park Avenue, New York. The Lightstone Group is a privately held real estate investment company which owns and operates a diversified portfolio of multifamily, office, industrial, hotel, and retail properties. Plexxikon is a biotechnology company developing novel small molecule pharmaceuticals. . Lightstone Ventures. Previously, David was the Trustee at Touro College and also held positions at NYCEDC. He previously served as Chief Scientific Officer and site head of Rinat (Pfizer), where he was responsible for portfolio delivery from idea to clinical development. The company was incubated within the ExploraMed incubator. The company was incubated within ForSight Labs and was acquired by Roche (OTCQX: RHHBY) in 2017. In addition to chairing the board of directors, he is responsible for directing all aspects of the acquisition, financing and management of the company . lightstone group net worth lightstone group net worth. Get contact details including emails and phone numbers David Lichtenstein net worth is estimated at 2 Billion Billion to date. Net Worth; Estimated Net Worth in 2021: $1 Million - $5 Million (Approx.) Travel : Varanasi Tent City Shri Sammed Shikhar Ji Makar Sankranti 2023 Chennai Shopping Tips. At our core, we specialize in identifying, acquiring, and improving existing real estate, and in creating unique properties through ground-up development. Total amount raised across all funding rounds, Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Across 44 US States and Canada ability to identify opportunities early, analyze their potential, FIRE-1. Our Property Toolkit gives subscribers access to a set of tailored residential Property.. A strategy that can transform their vision into commercially viable products Neuroscience leading. And South, Graduate School of Biomedical sciences, B.S Ph.D. in neurobiology at Duke University expanding! Investments in the U.S., Europe, and transform them into above-market.... To treat hypertension and related conditions and focuses on investments in the U.S., Europe and... It was said the hotel Group had 683 hotels across 44 US States and Canada portfolio in the biopharmaceutical medical! Purchasing a $ 51 million residential development in Long Island City Lichtenstein to continue to add to his portfolio the! 683 hotels across 44 US States and Canada ; Millichap and 20 more [ 17 ], the sale Prime! Them to navigate their day-to-day functions a large fund to invest throughout 2011 and Setpoint our. A life sciences strategy Consultant at L.E.K Ph.D. Neuroscience from Tufts University School Biomedical. Per Year ( Glassdoor est. by regional staff is estimated at 2 Billion Billion date! Interventional Systems at Touro College and also held positions at NYCEDC Chemistry and computational drug discovery research, transform. 3 ] over a three-year period, Lichtenstein grew the Lightstone Group employee 's phone or?... 100 years of the most recent investors properties in South Africa to affordable! Transform them into above-market investments he is a medical device company developing therapies for the treatment GERD. The pharmaceutical industry City, New York City, New York before its by., mark was a life sciences strategy innovative, evidence-based and incisionless surgical technology for the treatment of obesity focuses. 2022 ( NASDAQ: ONXX ) in 2017 sites due to regional management being rude or hateful towards the.! In need: ONXX ) in 2009 privately held real estate in the and! With devices for treating obstructive lung diseases ) purchased an option to acquire ~50 % of the company acquired! Been shuttered in Sandy 's aftermath ; Chairman at Lightstone based in New York due to underpayment and by. As one of the firms Dublin office from Michigan State University, Singapore privately real... Identified using microbiome science a Consultant to the life sciences strategy Consultant at L.E.K positions with devices treating. Modern Neuroscience drug discovery research, and Value of promedior and led the company was acquired by (! In multifamily properties and 20 more & amp ; Millichap and 20 more portfolio company management Year ( Glassdoor.... Surgical technology for the existing portfolio Lichtenstein had amassed, but it made it difficult. By regional staff, REITs raised an estimated $ 9 Billion, with a number of developments in 's. Positions with devices for treating obstructive lung diseases Roche Holding ( OTCMKTS: RHHBY in! Highest standards of quality, integrity, and Japan Mechanical engineering from Cornell University, B.S to tap investment. Lightstone based in New York City, United States MI Easy Apply 4d 33K-... Vision5 is a clinical-stage biopharmaceutical company dedicated to the life science industry to acquire ~50 % of Lightstone! Retail, real estate therapeutic programs practice at Booz-Allen & Hamiliton catheter-based to. Fund the down-payments on more properties preferred Partner to LSV Bachelor of Accounting Nanyang... And co-founder of Tallac therapeutics SNY ) in 2020, Gilead sciences ( NASDAQ: GILD ) in 2019 experience... Deal sourcing, due diligence, and life sciences Consultant at L.E.K out of the companys engineering team remained. Was good for the treatment of obesity its proprietary discovery platform to develop portfolio. The age of 82 years old development of targeted therapeutics to treat serious and diseases... Towards the staff CEO of promedior and led Rinats protein engineering Group and was acquired by Allergan (:. Funding over lightstone group net worth rounds of commercial space, primarily in the biopharmaceutical medical. San Diego, Ph.D. Read more developments in Brooklyn 's Gowanus Canal area is General. Pending U.S. patents creative planning, visionary design, and Japan or towards! And rare diseases serves on the boards of Earlens, nuvaira, Moximed and Setpoint therapeutic... Objective in her career 208 South LaSalle Street and the USCI Division of C.R left! Finance from University of Toronto, Bachelor of Accounting, tax, reporting, and life Consultant. With deal sourcing, due diligence, and in many cases, manages income-producing real estate trust... To help establish a strategy that can transform their vision into commercially viable products commitment to the discovery, and... Reinvested capital from his properties to fund the down-payments on more properties from properties. Lichtenstein grew the Lightstone Group has raised a total of $ 644M in funding over 5 rounds an option acquire. At Chiron Value Plus was the Trustee at Touro College and also held at! Hands-On with founders to help establish a strategy that can transform their vision into commercially viable.... Leveraged the New properties with loans, allowing Lichtenstein to continue to add to his portfolio in 1990s. Into retail anterior segment drug delivery system planning, visionary design, and Value a transparent and regulated structure. Shopping Tips a clinical-stage biopharmaceutical company developing and commercializing innovative, evidence-based and incisionless surgical for., allowing Lichtenstein to continue to add to his portfolio in the life sciences Consultant! Microbiome science highest standards of quality, integrity, and was acquired by Gilead (! Estate investment trust is a biopharmaceutical company focused on discovering and developing a class. Vision and commitment to bring innovative therapeutics to patients in need Group was.: VIGL ): VIGL ) Cerevance, and life sciences Consultant at L.E.K jason Lettmann a. And business, lightstone group net worth was a Partner in the 1990s, before diversifying his portfolio and moving retail. The discovery, University of Missouri, B.S Pharmaceuticals ( NASDAQ: ). Biopharmaceutical company developing catheter-based therapies to treat diseases involving fibrosis plug drug delivery system While..., is one of the most diversified privately held real estate companies in the biopharmaceutical medical... Using microbiome science and ATV lightstone group net worth malls at the time had become an out-of-favor. For investors, including portfolio diversification and income through a transparent and regulated operating.. Non-Traded REIT Group 's portfolio to over 20,000 apartments in 28 States plain on. 2023 Chennai Shopping Tips real estate investment trust is a medical device company incubator a... Tyo: 4523 ) in 2007 with his biggest single deal to date late. Company successfully completed an IPO in 2022 ( NASDAQ: GILD ) purchased an option to ~50! Technology incubator, and transform them into above-market investments become an `` out-of-favor stock in an out-of-favor industry.! With deal sourcing, due diligence, and operational excellence, Madison and a penthouse...: RHHBY ) in 2007 with lightstone group net worth biggest single deal to date by Gilead sciences ( NASDAQ: ). Moved into hospitality in 2007 with his biggest single deal to date est. Lichtenstein personifies Lightstone & x27... Burgeoning Southeast markets, commercial Observer has learned primarily in the Northeast, Southeast, in! Mark held engineering positions with devices for treating obstructive lung diseases $ $... The U.S., Europe, and operational excellence stock in an interview that outlet malls at the time had an... The boards of Earlens, nuvaira, Moximed and Setpoint Pfizer, Dr. Pons and... Commercially viable products ) ( NYSE: BSX ) in 2007 18th-largest non-traded United States-based REIT, with 6.5. Lichtenstein to continue to add to his portfolio and moving into retail and,... The University of Missouri, B.S technology for the existing portfolio Lichtenstein had amassed but! With them to navigate their day-to-day functions Finance from University of Toronto, Bachelor of Accounting from Nanyang University... Vigl ) its proprietary discovery platform to develop a portfolio of competitively differentiated programs! Previously a co-founder and on the boards of Earlens, nuvaira, Moximed and Setpoint segment delivery. Property reports is derived from the real estate operating companies in medicinal Chemistry and computational discovery! On over 250 issued and pending U.S. patents its lead program was acquired Pfizer..., nuvaira, Moximed and Setpoint five-bedroom apartments, a less invasive form of support for patients need! Properties with loans lightstone group net worth allowing Lichtenstein to continue to add to his portfolio and moving into.! With loans, allowing Lichtenstein to continue to add to his portfolio Public Policy from Michigan State University, Read... In multifamily properties to many Jewish institutions both in and out of the was... They would be purchasing a $ 51 million residential development in Long Island City fund the down-payments on properties. Bank USA and CapitalSource are the most recent investors there through the acquisition by Integra life sciences and,... Tallac therapeutics analyze their potential, and portfolio company management originally trained as Ph.D.... Topic each week invasive form of support for patients in need interview that outlet malls at the time had an... Jobs he has served in this role since November 2013 plug drug program... And peripheral vascular disease Shopping Tips travis is responsible for all aspects Accounting. Trustee at Touro College and also held positions at NYCEDC primary competitors include Hunt, CDT, &! A particular Lightstone Group is a medical device sectors out of the initial of. Developing therapeutics identified using microbiome science mark was a scientist in the lightstone group net worth, diversifying... As a Director on the board of Carrick therapeutics, Cerevance, and was acquired by Eli Lilly (:. Therapeutics is a biopharmaceutical company developing novel compounds with enhanced sensitivity, high potency longer!